https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
0
0
LRuas
https://www.optimumcomms.com/wp-content/uploads/2022/08/Optimum_Logo_Build.svg
LRuas2023-01-27 14:53:492023-01-27 14:53:49Jane Osbourn Presented with Lifetime Achievement Award by BIA
Jane Osbourn Presented with Lifetime Achievement Award by BIA
Optimum Strategic Communications sends our heartfelt congratulations…
The ‘must-attend’ Healthcare conferences of Q1 & Q2 2023
… And just like that it’s ANOTHER new year! If you are still…
Evaluate Vantage shares biopharma predictions for 2023
In this report, Amy Brown, Edwin Elmhirst and Joanne Fagg of…
2022 | Optimum’s Year in Review
It’s nearly the end of 2022! It was an exciting year for Optimum’s…
Sector Moves: November 2022
December moves 2022
Investment Firms
Avalon Ventures…
Investment Firms
Avalon Ventures…
Professor Melief of ISA Pharmaceuticals awarded 2 prestigious awards at the 37th Society for Immunotherapy of Cancer Annual Meeting
Congratulations to ISA Pharmaceuticals, Chief Scientific Officer…
LSX and Jefferies – Insights from the busiest week in European biotech
The LSX Inv€$tival Showcase kicked off a hectic week in life…
Panel Summaries from Optimum’s 14th Annual Healthcare Investor Conference 2022
For those that were unable to attend on Optimum’s 14th Annual…
Dan Mahony & Gareth Powell – Global healthcare investing: Can hindsight hone the crystal ball for the future? A fireside chat moderated by Amy Brown, Evaluate Vantage
Dan Mahony and Gareth Powell are long time, successful life sciences…
Financing growth: Walking the tightrope – Annual Healthcare Investor Conference Insight
Financing growth: Walking the tightrope
InsightIn the context…
InsightIn the context…
Can private markets continue to drive development in Life Sciences? – Insights from Optimum’s Healthcare Conference
We were proud to host a fantastic panel chaired by BioCentury’s…
Top takeaways from Mike Ward’s fireside chat with Werner Lanthaler, CEO of Evotec
We were privileged to hear visionary insights during Mike Ward’s…
Insights
We’d love to hear from you
For more information about Optimum Strategic Communications, please get in touch.
Current public market environment and equity investor views
/in InsightsBiotech is “hot” and M&A deals are likely to be an ongoing feature of the industry
/in InsightsScaling up a Company to $10bn-$20bn
/in Insights